Efficacy of Phenobarbital, Italept, and Topamax in treatment of Neonatal seizures: A double blinded cross sectional study of Iranian population Phenobarbital, Italept, and Topamax and Neonatal seizures
Iranian Journal of Child Neurology,
Vol. 18 No. 4 (2024),
29 September 2024
,
Page 81-91
https://doi.org/10.22037/ijcn.v18i4.43760
Abstract
Objectives
Seizures are changes in the electrical activity of the brain. These changes can cause significant or otherwise asymptomatic symptoms. Phenobarbital and phenytoin are known drugs for treating neonatal seizures, but little clinical experience exists using other drugs. The present study aims to evaluate the efficacy of other drugs, such as Levetiracetam and Topiramate, compared to Phenobarbital in treating neonatal seizures.
Materials & Methods
In a double-blind clinical trial, all neonates admitted to a referral hospital for two years (2020-2022) due to seizures were included. All of the neonates were treated with a dosage of 10-40mg/kg/state IV Phenobarbital to control the acute seizure. After that, they were divided into three groups with specific treatment programs. Groups were ordered with oral Phenobarbital 5mg/kg/day maintenance (first group), oral Topiramate 3-8mg/kg/day (second group), and 10-40mg/kg/day Levetiracetam (third group). Seizures and potential side effects were investigated through interviews and medical EEG tests. The data was analyzed using the Chi-square test.
Results
Sixty infants (20 neonates in each group) were studied. Phenobarbital, Italept, and Topiramate did not significantly differ in controlling convulsions and changes related to brain paroxysmal discharges.
Conclusion
Due to the long treatment duration and side effects, it is essential to choose the appropriate drug for treating treatment-resistant seizures of neonates. The present study found that Phenobarbital, Levetiracetam, and Topiramate are equally effective in controlling seizures. These medications can also help eliminate abnormalities in children’s brain paroxysmal
- Seizure, Neonate, drugs, EEG
How to Cite
References
Smeltzer SCC, Bare BG. Brunner & Suddarth's textbook of medical-surgical nursing: JB Lippincott Philadelphia; 1992.
Mussavi M, Khanzadeh S, Sadeghvand S, Hasanpour E, Akbari M, Nasiri S, et al. Brain CT Scan, Sonography and EEG Findings in Neonates with Seizure. Iranian Journal of Child Neurology. 2022;16(3).
D Howland R, J Mycek M. Lippincott's illustrated reviews: Pharmacology: Lippincott Williams& Wilkins; 2006.
Temko A, Thomas E, Marnane W, Lightbody G, Boylan G. EEG-based neonatal seizure detection with support vector machines. Clinical Neurophysiology. 2011;122(3):464-73.
Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. New England Journal of Medicine. 1999;341(7):485-9.
Nimaga K, Desplats D, Doumbo O, Farnarier G. Treatment with phenobarbital and monitoring of epileptic patients in rural Mali. Bulletin of the World Health Organization. 2002;80:532-7.
Lerman-Sagie T, Lerman P. Phenobarbital still has a role in epilepsy treatment. Journal of child neurology. 1999;14(12):820-1.
Millson RC, Owen JA, Lorberg GW, Tackaberry L. Topiramate for refractory schizophrenia. American Journal of Psychiatry. 2002;159(4):675-.
Menkes JH, Sarnat HB, Maria BL. Child neurology: Lippincott Williams & Wilkins; 2006.
Nemati H, Talebianpour H, Lotfi F, Sepehri NZ, Keshavarz K. Cost-effectiveness analysis of topiramate versus phenobarbital in the treatment of children with febrile seizure. Iranian Journal of Child Neurology. 2019;13(4):109.
Leppik IE. Quality of life of people with epilepsy in the United States. Clinical therapeutics. 1998;20:A13-A8.
Wyllie E, Cascino GD, Gidal BE, Goodkin HP. Wyllie's treatment of epilepsy: principles and practice: Lippincott Williams & Wilkins; 2012.
Talebianpour H, Talebianpour E, Sadeghkhani O, Jafari A. Study of the Quality of Life in Patients with Chronic Renal Failure Treated with Hemodialysis. Journal of Health Based Research. 2019;4(4):399-410.
Swaiman KF, Ashwal S, Ferriero DM. Pediatric neurology: principles & practice: Elsevier Health Sciences; 2006.
Wyllie E, Gupta A, Lachhwani DK. The treatment of epilepsy: principles & practice: Lippincott Williams & Wilkins; 2006.
Prokopczyk J, Piekarczyk A, Kaminska E. Is therapeutic drug monitoring (TDM) in paediatric patients necessary? Medycyna Wieku Rozwojowego. 2001;5(2):149-55.
Rey E, Tréluyer J-M, Pons G. Pharmacokinetic optimisation of benzodiazepine therapy for acute seizures: focus on delivery routes. Clinical pharmacokinetics. 1999;36(6):409-24.
- Abstract Viewed: 383 times